Goldman Sachs’s BIND THERAPEUTICS INC BIND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-28,921
Closed -$11K 7436
2016
Q2
$11K Buy
+28,921
New +$23.7K ﹤0.01% 6852
2015
Q2
Sell
-14,170
Closed -$78K 7699
2015
Q1
$78K Buy
14,170
+1,065
+8% +$6.54K ﹤0.01% 6536
2014
Q4
$71K Buy
+13,105
New +$98.3K ﹤0.01% 6703

Goldman Sachs's BIND Position: Q3 2016 in Review

Goldman Sachs sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 28,921 shares — an estimated $11K sold.

Goldman Sachs first reported a position in BIND in Q4 2014 and held it in 3 quarters. The position peaked at $78K in Q1 2015. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

  • Goldman Sachs reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Goldman Sachs sold 28,921 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $11K.
  • Goldman Sachs first reported a position in BIND THERAPEUTICS INC in Q4 2014 and held it in 3 quarters.
  • Goldman Sachs's BIND THERAPEUTICS INC position peaked at $78K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Goldman Sachs's 13F filing for Q3 2016, filed 14 Nov 2016.